RENAL HISTOLOGY AND INTERSTITIAL MORPHOMETRY IN NEPHROTIC PATIENTS TREATED WITH CYCLOSPORINE

被引:0
|
作者
POVEDA, R
CARRERA, M
MORESO, F
CARRERAS, L
GONZALEZ, MT
ALSINA, J
机构
来源
NEFROLOGIA | 1995年 / 15卷 / 03期
关键词
NEPHROTIC SYNDROME; CYCLOSPORINE; RENAL MORPHOMETRY;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Renal biopsies were performed in six adult patient with steroid-resistant or steroid-dependent idiopathic nephrotic syndrome after low-dose CsA therapy. Their histologic diagnoses were MCD (3), Mesangial proliferative GN (1) and FSGS (2). CsA therapy was started at 3 mg/kg/day. Prednisone at 10 mg/kg/day was also given. Remission after therapy was noted in all but one (FSGS/steroid resistant) patient. Mean CsA dose ranged from 3 to 4 mg/kg/day and blood CsA levels from 56 to 110 ng/ml. Therapy was maintained for 12-15 months in CsA responders and for three months in the case of CsA resistance. GFR (Clearance of 51 Cr EDTA) remained within normal limits. Renal biopsies were performed prior to the start of CsA treatment and repeated in the days before the end of therapy. Using semiquantitative methods (Score 1+ to 4+), slight (1+) glomerular and tubulointerstitial sclerotic changes were disclosed only in the two cases with previous steroid-resistance. No vascular changes were observed. Morphometrical analysis of the interstitial surface (IS) was performed by point-counting methods. A decrease of IS during therapy was observed in two patients wich was associated with a good subsequent clinical course: Sustained remission of nephrotic syndrome after stopping CsA (Follow-up 34 months). On the contrary, increased IS during therapy was associated with early relapse after discontinuation of CsA (3 cases) or CsA resistance (1 case).
引用
收藏
页码:252 / 257
页数:6
相关论文
共 50 条
  • [41] EFFECTS OF ISRADIPINE ON RENAL-FUNCTION IN CYCLOSPORINE-TREATED RENAL TRANSPLANTED PATIENTS
    BERG, KJ
    HOLDAAS, H
    ENDRESEN, L
    FAUCHALD, P
    HARTMANN, A
    PRAN, T
    SOLBU, D
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1991, 6 (10) : 725 - 730
  • [42] INTERSTITIAL FIBROSIS IN RENAL-ALLOGRAFTS IN PATIENTS TREATED WITH CYCLOSPORIN
    FARNSWORTH, A
    HALL, BM
    DUGGIN, GG
    HORVATH, JS
    TILLER, DJ
    LANCET, 1984, 2 (8417): : 1470 - 1471
  • [43] PHARMACOKINETICS OF CYCLOSPORINE-A IN PATIENTS WITH NEPHROTIC SYNDROME
    VERNILLET, L
    MOULIN, B
    DADOUN, C
    LEBIGOT, JF
    FILLASTRE, JP
    TRANSPLANTATION PROCEEDINGS, 1988, 20 (02) : 529 - 535
  • [44] CYCLOSPORINE A(CSA) IN PATIENTS WITH IDIOPATHIC NEPHROTIC SYNDROME
    ZIETSE, R
    WENTING, GJ
    KRAMER, P
    SCHALEKAMP, MADH
    WEIMAR, W
    KIDNEY INTERNATIONAL, 1988, 33 (05) : 1035 - 1035
  • [45] TREATMENT WITH CYCLOSPORINE OF PATIENTS WITH IDIOPATHIC NEPHROTIC SYNDROME
    MEYRIER, A
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1987, 9 (04): : 441 - 450
  • [46] TOPHACEOUS GOUT IN PATIENTS WITH RENAL-TRANSPLANTS TREATED WITH CYCLOSPORINE-A
    BAETHGE, BA
    WORK, J
    LANDRENEAU, MD
    MCDONALD, JC
    JOURNAL OF RHEUMATOLOGY, 1993, 20 (04) : 718 - 720
  • [47] RENAL-FUNCTION IN PATIENTS WITH AUTOIMMUNE-DISEASES TREATED WITH CYCLOSPORINE
    VONGRAFFENRIED, B
    HARRISON, WB
    TRANSPLANTATION PROCEEDINGS, 1984, 17 (04) : 215 - 231
  • [48] HYPERTENSION AFTER RENAL-TRANSPLANTATION IN PATIENTS TREATED WITH CYCLOSPORINE AND AZATHIOPRINE
    GORDJANI, N
    OFFNER, G
    HOYER, PF
    BRODEHL, J
    ARCHIVES OF DISEASE IN CHILDHOOD, 1990, 65 (03) : 275 - 279
  • [49] Renal function in patients with cadaveric kidney transplants treated with tacrolimus or cyclosporine
    Molina, M. Gonzalez
    Morales, J. M.
    Marcen, R.
    Campistol, J. M.
    Oppenheimer, F.
    Seron, D.
    Gil-Vernet, S.
    Capdevila, L.
    Andres, A.
    Lampreave, I.
    Del Castillo, D.
    Cabello, M.
    Burgos, D.
    Valdes, F.
    Anaya, F.
    Escuin, F.
    Arias, M.
    Pallardo, L.
    Bustamante, J.
    TRANSPLANTATION PROCEEDINGS, 2007, 39 (07) : 2167 - 2169
  • [50] RENAL-ALLOGRAFT SURVIVAL IN HIGHLY SENSITIZED PATIENTS TREATED WITH CYCLOSPORINE
    DORAN, M
    RUTH, J
    LOWERY, B
    FISH, J
    WINSETT, O
    VAIDYA, S
    HUMAN IMMUNOLOGY, 1986, 17 (02) : 116 - 116